19. Dezember 2019 – The Federal Department of Home Affairs (FDHA) has decided that two new autologous cell therapies (CAR-T therapies) for the treatment of blood and lymph gland cancer will in future be covered by compulsory health care insurance. In addition, preventive investigations of colorectal cancer will be exempted from the franchise in the Cantons Fribourg and Basel-Stadt. In addition to these changes, a number of other adaptations have been made to the Health Care Benefits Ordinance (Krankenpflege-Leistungsverordnung, KLV; SR 832.112.31) and its annexes. All amendments to the KLV will enter into force on 1 January 2020. For further information, see here.